Mylan surges, Teva slumps after FDA approves Copaxone copy | Reuters.com
The Teva vs. Mylan drug war - The Jerusalem Post
Teva, Mylan Drop on Announcement of Epinephrine Injector Rival | Ctech
Mylan sues generic rival Teva over 'sophisticated scheme' to block Copaxone copycats | Fierce Pharma
Generic EpiPen by Teva Wins FDA Nod After 2 Year Delay | Fierce Pharma
Teva, Mylan: Desperate Times Call For Desperate Measures (NYSE:TEVA) | Seeking Alpha
Mylan rejects Teva takeover bid as too low | Mint
FDA swats down Teva's EpiPen copy, putting Mylan in cruise control | Fierce Pharma
Tamoxifen Detective: How I got my Teva back | The small c
Drugmaker Teva makes $40B bid for rival Mylan
Teva Launches Site for Generic EpiPen Equivalent | SnackSafely.com
Teva settles litigation with Mylan over Nuvigil - Pharmaceutical Technology
Lawmakers accuse drugmakers Mylan, Teva of 'coordinated obstruction'
Teva Won't Let Regulators, Poison Pill Stop Its Quest for Mylan - TheStreet
FDA Approves Teva's Generic EpiPen As Stock Rises
Teva shares rival Mylan's pain as both hit two-year lows | Fierce Pharma
$40B deal: Teva offers to buy Mylan
Teva Projects Generic Version of EpiPen to Consist of a Quarter of US Market | The Jewish Press - JewishPress.com | Jewish News Syndicate (JNS) | 16 Adar I 5779 – February 21, 2019 | JewishPress.com
Teva's Deal for Mylan Shows Corporate Israel's M&A Hunger - WSJ
Mylan vs. Teva: Which Is the Better Generics Stock Ahead of Earnings?
Teva Pharmaceutical Gains Approval For Generic EpiPen, Mylan Shares Flat
Teva prices EpiPen generic at $300, same price as Mylan generic
Mylan Teva EpiPen Generic Auto-Injector Market
Therapeutically equivalent to EpiPen®
Teva makes $40 billion offer for Mylan
Mylan vs Teva Pharmaceuticals | Comparably
How Mylan tried to keep Teva from selling a generic EpiPen
Mylan vs. Teva: Which Is the Better Generics Stock Ahead of Earnings?
